CBT for schizophrenia: a critical viewpoint
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In England and Wales, cognitive behavioral therapy (cognitive therapy, CBT) has been part of official treatment guidelines for schizophrenia since 2002 (NICE, 2009, p. 212).The 2014 NICE guideline (NICE, 2014), which is based on the same meta-analytic evidence as its predecessor in 2009, recommends that it be offered to all people with schizophrenia, including first-episode patients and those with established illness, and to patients who are actively symptomatic and in remission.Similar recommendations are to be found in the Scottish SIGN guideline (SIGN, 2013) as well as those of several other countries (Rathod et al., 2010).In 2012, however, the Cochrane collaboration sounded a discordant note, concluding that '[t]rial-based evidence suggests no clear and convincing advantage for cognitive behavioural therapy over other-and sometimes much less sophisticated-therapies for people with schizophrenia' (Jones et al., 2012).A further challenge came from a 2014 meta-analysis carried out by ourselves (Jauhar et al., 2014), which found end of treatment effect sizes (ESs) that were uniformly in the small range [overall symptoms: 0.33 (95% CI 0.19-0.47),34 studies; positive symptoms: 0.25 (95% CI 0.13-0.37),33 studies; negative symptoms: 0.13 (95% CI 0.01-0.25),34 studies] (note these and all further ESs are shown as a positive sign favoring CBT).A 2018 network meta-analysis of various psychological interventions to reduce positive symptoms in schizophrenia (Bighelli et al., 2018), carried out on a rather different dataset of 27 studies than us, again found pooled ESs for CBT in the small range, though this time at the upper end of this [v.treatment as usual (TAU): 0.30 (95% CI 0.14-0.45),18 trials; v. inactive control interventions: 0.29 (95% CI 0.03-0.55),seven trials] (Bighelli et al., 2018).Most recently, a 2018 update of the 2012 Cochrane meta-analysis has continued to find no clear or convincing evidence of superiority on any measure apart from leaving the study early (Jones et al., 2018).In the wake of a 'viewpoint' article examining whether it is right to continue to regard CBT as a gold standard for depression and anxiety (Leichsenring and Steinert, 2017), we consider the current status of this form of therapy in schizophrenia and the related psychotic disorders that are typically included in trials (schizoaffective disorder, delusional disorder, and psychosis not otherwise specified).We draw on what can legitimately be regarded as the two best sources of evidence, namely meta-analyses and large, well-conducted individual trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allocation concealment in randomised trials: defending against deciphering
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07750-4 · Cited by 923
Jauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116285 · Cited by 517 · cited 6×
“In our 2014 meta-analysis (Jauhar et al., 2014), we found a significant moderating effect of blinding: the pooled ES reduced from 0.”
BackgroundMethodResultInfluentialMorrison, A. P., French, P., Stewart, S. L. K., Birchwood, M., Fowler, D., Gumley, A. I., Jones, P. B., Bentall, R. P., Lewis, S. W., Murray, G. K., et al. (2012) · BMJ · doi:10.1136/bmj.e2233 · Cited by 332
Garety, P. A., Fowler, D. G., Freeman, D., Bebbington, P., Dunn, G., & Kuipers, E. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.043570 · Cited by 296
Freeman, D., Dunn, G., Startup, H., Pugh, K., Cordwell, J., Mander, H., Černis, E., Wingham, G., Shirvell, K., & Kingdon, D. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00039-5 · Cited by 295
van der Gaag, M., Valmaggia, L. R., & Smit, F. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.016 · Cited by 271
Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis
Davies, C., Cipriani, A., Ioannidis, J. P. A., Radua, J., Stahl, D., Provenzani, U., McGuire, P., & Fusar‐Poli, P. (2018) · World Psychiatry · doi:10.1002/wps.20526 · Cited by 229
van der Gaag, M., Nieman, D. H., Rietdijk, J., Dragt, S., Ising, H. K., Klaassen, R. M. C., Koeter, M., Cuijpers, P., Wunderink, L., & Linszen, D. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs105 · Cited by 209
Cognitive-behavioral therapy for medication-resistant psychosis: A meta-analytic review
Burns, A. M. N., Erickson, D. H., & Brenner, C. A. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300213 · Cited by 199 · cited 1×
“(Burns et al. 2014) meta-analyzed randomized trials of CBT in medicationresistant patients, finding apparently substantial end of treatment effect sizes of 0.”
MethodCognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis
Hutton, P., & Taylor, P. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000354 · Cited by 184
Cited by
Marder, S. R., & Cannon, T. D. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1808803 · Cited by 529
Leichsenring, F., Steinert, C., Rabung, S., & Ioannidis, J. P. A. (2022) · World Psychiatry · doi:10.1002/wps.20941 · Cited by 485
Mindfulness-Based Interventions for People with Schizophrenia: A Systematic Review and Meta-Analysis
Hodann-Caudevilla, R. M., Díaz-Silveira, C., Burgos-Julián, F. A., & Santed, M. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134690 · Cited by 60
“Although there is a certain amount of controversy regarding its effectiveness in the treatment of schizophrenia [21], on the whole, research yields positive results, especially in the decrease of positive symptoms [22–24].”
ResultTaylor, M., & Jauhar, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319870033 · Cited by 51
Self-citationBöge, K., Hahne, I., Bergmann, N., Wingenfeld, K., Zierhut, M., Thomas, N., Ta, T. M. T., Bajbouj, M., & Hahn, E. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.008 · Cited by 44
Metadata
- Authors
- Jauhar, S., Laws, K. R., & McKenna, P. J.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2019-02-13
- Volume
- 49
- Issue
- 8
- Pages
- 1233-1236
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2913295997
- Cited by
- 52
- References
- 13
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CBT for schizophrenia: a critical viewpoint. https://app.cochat.ai/papers/10.1017/s0033291718004166
- The paper
- Jauhar, S., Laws, K. R., & McKenna, P. J. (2019). CBT for schizophrenia: a critical viewpoint. Psychological Medicine. https://doi.org/10.1017/s0033291718004166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.